▶ To maintain the US FDA-approved IND for the future out-licensing deal ▶ Plan to proceed Phase 2 with a new out-licensing partnership ▶ AMR problem became much more serious than ever ▶ SAL200 will be AMR solution as a […]
By using this website, you agree to us using cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.